Biomedicines 和 Cancers 邀您共赴中国肿瘤标志物学术大会 (CCTB大会) | MDPI 会议信息
发表时间:2023-03-28 阅读量:185
中国肿瘤标志物学术大会暨 CACA 整合肿瘤学峰会暨第十六届肿瘤标志物青年科学家论坛暨中国肿瘤标志物产业创新大会 (CCTB 大会) 将于2023年4月7日至9日,以四会联办的形式在上海隆重召开!MDPI 期刊将在 #B155 展位与您见面!届时,您将在展位上了解到 Biomedicines、Cancers、Cells、Diagnostics、Current Oncology、Journal of Personalized Medicine (JPM)、Journal of Clinical Medicine (JCM)、Onco、Current Issues in Molecular Biology (CIMB)、BioMedInformatics 期刊与 MDPI 服务等信息与资讯,期待与您相聚。
会议地点:上海跨国采购会展中心
会议介绍
新型肿瘤标志物及其相关领域的基础研究、前沿技术、临床应用、产业发展等方面不断取得重大突破。为促进多学科整合、全方位合作,四场高水平大会共同秉承“创新、转化、合作、共享”理念,通过全方位、多视角、多学科交叉融合,邀请近500位医研企专家,精心打造40余个主题论坛及专题活动,充分展示肿瘤标志物及其相关领域最新研究成果。本届大会再次入选中国科协《重要学术会议指南》,是肿瘤标志物领域最高学术水平的交流盛宴,预计参会人数将历史性突破5000人。
2023年是肿瘤防治事业迈入三年抗疫后常态化的开局之年,在疫情的磨砺下,这个春天必将更加富有生机与活力,期待与您跨越山海,相聚上海,共同见证 CCTB 学术盛宴!本届学术研讨会共设置4个主题。会议交流方式包括大会特邀报告、专题报告,以及相关检测技术培训等。现诚邀全国肿瘤标志物学同仁参加此次会议,申请各主题的报告。
会议主题
中国肿瘤标志物学术大会;
中国整合肿瘤学大会;
中国肿瘤标志物青年科学家论坛;
中国肿瘤标志物产业创新大会。
展位信息
展位号:#B155
相关特刊
Biomedicines:
Clinical Immunology in Italy, with Special Emphasis to Primary and Acquired Immunodeficiencies: A Commemorative Issue in Honor of Prof. Fernando Aiuti
Edited by Isabella Quinti, Alessandro Aiuti, Raffaele D'Amelio and Paolo Rossi
Submission Deadline: 31 March 2023
https://www.mdpi.com/journal/biomedicines/special_issues/Commemorative_Prof_Aiuti
Breast Cancer: From Pathophysiology to Therapeutic Strategies
Edited by Xuemei Xie, Toshiaki Iwase and Jangsoon Lee
Submission Deadline: 30 June 2023
https://www.mdpi.com/journal/biomedicines/special_issues/2AT2ZK1883
Immune Inhibitory Mechanisms and New Insights into Ovarian Cancer Treatment
Edited by Iwona Wertel and Agnieszka A. Bojarska-Junak
Submission Deadline: 31 July 2023
https://www.mdpi.com/journal/biomedicines/special_issues/Ova_rian
Tumor Microenvironment: From Cellular Components to Therapeutic Perspectives
Edited by Adriana Grigoraș and Cornelia Amalinei
Submission Deadline: 30 November 2023
https://www.mdpi.com/journal/biomedicines/special_issues/Z7047FQSG9
Cancers:
Novel Biomarkers in Pancreatic Cancer
Edited by Damiano Caputo, Daniela Pozzi and Alessandro Coppola
Submission Deadline: 1 May 2023
https://www.mdpi.com/journal/cancers/special_issues/Biomarkers_Pancreatic
Early Detection of Cancer and Its Recurrence – Technologies and Biomarkers to Enhance Clinical Translation
Edited by Rajan P. Kulkarni
Submission Deadline: 31 May 2023
https://www.mdpi.com/journal/cancers/special_issues/769247OC74
The Microbiome-Immunity-Cancer Axis in Cancers
Edited by Anquan Shang, William Cho and Zongxin Ling
Submission Deadline: 31 May 2023
https://www.mdpi.com/journal/cancers/special_issues/02644RPJ68
主要参展期刊
Biomedicines 期刊介绍
主编:Shaker A. Mousa, Albany College of Pharmacy and Health Sciences, USA
期刊主题涵盖人类健康和疾病的所有方面,如疾病的发病机制、转化医学、纳米医学、基因疗法、细胞疗法、生物制品、生物医学研究中的生物材料、天然生物活性分子、生物相似物、靶向特异性抗体以及重组治疗蛋白等。目前期刊已被 SCIE、Scopus 和 PubMed 等数据库收录。
2021 Impact Factor:4.757
2021 CiteScore:3.0
Time to First Decision:17 Days
Time to Publication:36 Days
Cancers 期刊介绍
主编:Samuel C. Mok, The University of Texas MD Anderson Cancer Center, USA
期刊主题涵盖癌症治疗和免疫疗法、癌症生物标志物、流行病学和预防、肿瘤微环境、癌症病因和筛查、诊断和护理、癌症分子生物学等肿瘤学领域的各个方面。目前,期刊已被SCIE、Scopus、pubmed等重要数据库收录。
2021 Impact Factor:6.575
2021 CiteScore:5.8
Time to First Decision:17.4 Days
Time to Publication:40 Days